This study was designed to investigate the prevalence of hepatitis B virus (HBV) genotypes in Tibetan and Han nationalities in Sichuan Province, China, and their clinical significance. Sera from 376 patients (286 Han nationals, 90 Tibetan nationals) were genotyped by polymerase chain reaction. Of the 286 Han nationals, 127 were HBV asymptomatic carriers, 90 were symptomatic patients and 69 had hepatocellular carcinoma. The distribution of HBV genotypes was related to geography as well as ethnicity. The HBV genotype frequencies were: B, 57.9%; C, 16.0%; and BC, 26.1%. Association studies between genotypes and clinical laboratory outcomes showed HBV genotype C to be more virulent. There was a higher prevalence of mixed genotype BC in Tibetan nationals compared with Han nationals. There was no synergistic effect in terms of virulence in patients coinfected with genotypes B and C.
Introduction
Hepatitis B virus (HBV) exhibits genetic variation and has been classified into eight genotypes (A -H) on the basis of an intergroup divergence of ≥ 8%. 1 The distribution of HBV genotypes varies with geographical location 2 and ethnic group. 3, 4 Heterogeneity of HBV may result in differences in the clinical outcomes of patients infected with HBV, such as the time to hepatitis B e antigen (HBeAg) seroconversion, 5, 6 the severity of liver damage and their response to antiviral treatment. 7 Thus, knowledge of all the HBV genotypes with which patients in a particular district are infected is important for the proper and effective management of HBV. 8 To the authors' knowledge, there are no previously published data that compare the HBV genotype distributions between the two nationalities, Han and Tibetan nationals, living in Sichuan Province. The aim of this study was, therefore, to investigate this and Prevalence of HBV genotypes in two Chinese populations to examine any correlation between HBV genotypes in these two nationalities and clinical laboratory outcomes.
Patients and methods

PATIENTS
This observational study included Tibetan and Han people who were admitted to West China Hospital of Sichuan University between October 2008 and February 2009, and who were positive for hepatitis B surface antigen (HBsAg) or who had HBV viral loads ≥ 1000 copies/ml. All patients attending the hospital for routine health checks or who were consulting a doctor for another reason were sequentially screened. No known bias existed in the collection of samples. Duplicate samples from the same patient were eliminated. Patients with hepatitis C, hepatitis D or human immunodeficiency virus (HIV) co-infection were excluded. This study received ethical approval from the Ethical Committee of West China Hospital of Sichuan University. All patients participating in the study provided written informed consent for sample collection and subsequent analysis.
Laboratory diagnostic data on the enrolled patients, including the outcomes of tests for HBV serological markers (HBeAg and hepatitis B e antibody [HBeAb] detected by enzyme-linked immunosorbent assay) and biochemical tests such as for alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, were collected retrospectively. Males with ALT > 55 U/l or AST > 38 U/l and females with ALT > 46 U/l or AST > 37 U/l were classified as having abnormal levels of these enzymes, and this was the standard for classifying patients as symptomatic (Ab) or asymptomatic carriers (ASC).
DETECTION OF HBV GENOTYPES
Blood samples obtained from the Tibetan and Han nationals were used to identify HBV genotypes. For each patient, DNA was extracted from 100 µl of serum using Chelex 100 (KeHua Bio-Engineering Co. Ltd, Shanghai, China), according to the manufacturer's instruction. DNA amplification and detection of HBV genotypes were performed using a nested polymerase chain reaction assay as described previously. 9 -12 
STATISTICAL ANALYSIS
Data were analysed using the χ 2 -test, Student's t-test, analysis of variance and Student-Newman-Keuls test where appropriate. Statistical analyses were carried out using the SPSS ® statistical package, version 13.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . Differences with P-values < 0.05 were considered to be statistically significant.
Results
In total, 376 patients from Sichuan Province were enrolled in the study, comprising 90 Tibetan and 286 Han nationals. Among the Han nationals, 127 were HBV asymptomatic carriers (ASC), 90 were symptomatic patients (Ab) and 69 had hepatocellular carcinoma (HCC). The ages and gender ratios of the patients are shown in Table 1 . Among Han nationals who had HCC, the ages and gender ratios were significantly different to those of Han nationals who were ASC or Ab, or Tibetan nationals (P < 0.05). Table 2 shows the prevalence of the B, C and BC genotypes for HBV in the Tibetan and Han patients. There was a significantly higher prevalence of the mixed genotype BC (62.2%) among Tibetan nationals compared with any of the subgroups of Han nationals (P < 0.05). In the three groups of Han patients studied, the prevalence of genotype B was significantly higher (81.1%) and the prevalence of genotype C was significantly Prevalence of HBV genotypes in two Chinese populations lower (7.9%) in the ASC group compared with both the Ab and HCC groups (P < 0.05). There was no significant difference in the distribution of mixed genotype BC between the three clinical phenotypes (ASC, Ab and HCC) among Han patients. Table 3 shows the relationship between the B, C and BC genotypes for HBV and laboratory outcomes. The serological outcomes (HBeAg and HBeAb) and biochemical outcomes (ALT and AST levels) were all associated with the prevalence of particular HBV genotypes. The proportion of patients positive for HBeAg was significantly higher among patients with genotype C versus those with genotype B or the mixed BC genotype (P < 0.05), whereas there was no significant difference between patients with 
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Discussion
In the course of HBV infection, the clinical phenotype varies with the different HBV genotypes. 13 Studies have found more severe liver disease to be associated with genotype C than with genotype B. 14, 15 Different HBV genotype strains have their own relatively obvious geographical distribution. Up to now, four genotypes (A, B, C and D) have been reported in China. The present study demonstrated that genotypes B (57.9%), C (16.0%) and BC (26.1%) exist among the two nationalities (Tibetan and Han) in the Sichuan Province of China, which supports the view that the infection ratio of genotype B gradually rises from the north to the south of China. 16 The prevalence of the three genotypes in Tibetan and Han nationals was significantly different (P < 0.05), with the most prominent difference being the significantly high prevalence (62.2%) of the mixed genotype BC among Tibetan nationals compared with the Han population from the same area. This difference seems to be nationality related. 17, 18 The prevalence of HBV genotypes may be influenced both by the ethnicity of the HBV host and by transmission of HBV, which itself can be influenced by human behaviour. High prevalence of the mixed HBV genotype BC can also be found in Bai nationals in the Yunnan Province of China, at a prevalence rate of 34% 19 and in intravenous drug users. 20 There was a significant difference in the present study in the distribution of clinical phenotypes (ASC, Ab and HCC) in Han patients infected with different HBV genotypes. Patients with genotype B were significantly more likely to be ASC than Ab or HCC (P < 0.05), whereas patients with genotype C were significantly more likely to have be Ab than ASC or HCC (P < 0.05).
The marker of HBV strain replication and infectivity is the HBeAg. Studies evaluating an association between the rate of HBeAg or HBeAb positivity and genotypes B and C have shown conflicting results. 11, 16, 21 The present study demonstrated that patients infected with HBV genotype B had significantly lower HBeAg and significantly higher HBeAb positivity rates compared with those infected with genotype C. This could be attributed to earlier HBeAg seroconversion following infection with HBV genotype B than with HBV genotype C infection. 22 Mutations in the basal core promoter region which can affect the expression of HBeAg should also be taken into consideration.
The clinical phenotypes, such as ASC and HCC, were related to HBV genotype. Levels of ALT and AST can, to some degree, quantitatively reflect the level of hepatocyte injury. The ALT and AST levels in patients infected with genotype C were significantly higher than in those patients infected with either genotype B or the BC mixed genotype (P < 0.05). Thus, both biochemical and serological outcomes suggested that the HBV genotype C strain was more virulent than the genotype B strain. When HCC patients were considered separately, it was interesting to note that there were no significant differences in AST and ALT levels amongst the three genotypes and that co-infection with the mixed genotype BC did not lead to significant elevation in ALT or AST levels. This may be due to the small sample size used in the present study, or it may be due to lack of a synergistic effect in terms of HBV virulence with co-infection of genotypes B and C. It may also be explained by the fact that liver function is severely compromised in the HCC stage of the HBV infection, affecting the ability to produce liver enzymes.
In conclusion, this study suggests that the unique distribution of HBV genotypes is related to geography as well as ethnicity. The HBV genotypes B, C and BC were shown to be prevalent in the two nationalities (Tibetan and Han) living in Sichuan Province. The most prominent characteristic noted was the higher prevalence of the mixed genotype BC in Tibetans versus Han nationals in Sichuan Province. The prevalence of HBeAg positivity was significantly lower and HBeAb was significantly higher among patients infected with genotype B than those infected with genotype C, and significantly higher levels of ALT and AST were observed with HBV genotype C, suggesting that genotype C is more virulent than genotype B. There was, however, no synergistic effect observed in terms of HBV virulence in patients coinfected with genotypes B and C.
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